• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面活性剂对阳离子固体脂质纳米粒理化特性的影响。

Surfactant effect on the physicochemical characteristics of cationic solid lipid nanoparticles.

作者信息

Botto Chiara, Mauro Nicolò, Amore Erika, Martorana Elisabetta, Giammona Gaetano, Bondì Maria Luisa

机构信息

Laboratorio di Polimeri Biocompatibili, Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy.

Istituto per lo Studio dei Materiali Nanostrutturati (ISMN), CNR, U.O.S. Palermo, via Ugo La Malfa, 153, 90146 Palermo, Italy.

出版信息

Int J Pharm. 2017 Jan 10;516(1-2):334-341. doi: 10.1016/j.ijpharm.2016.11.052. Epub 2016 Nov 23.

DOI:10.1016/j.ijpharm.2016.11.052
PMID:27889586
Abstract

Solid lipid nanoparticles (SLNs) may be considered as a new approach for therapeutics for many diseases. In addition to drug delivery, their use as non-viral vectors for gene delivery can be obtained by including cationic lipids, which provide a positive surface potential that favors binding to the nucleic acids as DNA, siRNA, miRNA, etc. In fact, the addition of cationic surfactants is indispensable for obtaining nanoparticles with surface positive charge. In this study, three different cationic lipids (dioctadecyl dimethyl ammonium bromide, cetyltrimethyl ammonium bromide, cetylpyridinium chloride) and Brij 76 as nonionic surfactant were employed to formulate Precirol ATO 5 based cSLN using pEGFP-LUC as model plasmid. The physicochemical properties of cSLN were influenced by both type and amount of surfactants. Thermal analyses of bulk cSLN showed endothermic peaks significantly different from the ones of the single pure components, hinting a complete entanglement of the lipid matrix with the surfactants and justifying the different behavior of the cSLN in the ability to interact with the plasmid DNA. Finally, the biocompatibility of cSLN was demonstrated by hemolytic assays. These results may give an insight into the choice of surfactants in order to obtain non-toxic and highly effective delivery systems for gene therapy.

摘要

固体脂质纳米粒(SLNs)可被视为治疗多种疾病的一种新方法。除了药物递送外,通过加入阳离子脂质可使其用作基因递送的非病毒载体,阳离子脂质可提供正表面电位,有利于与DNA、siRNA、miRNA等核酸结合。事实上,添加阳离子表面活性剂对于获得具有表面正电荷的纳米粒是必不可少的。在本研究中,使用三种不同的阳离子脂质(二辛基二甲基溴化铵、十六烷基三甲基溴化铵、十六烷基吡啶氯化物)和作为非离子表面活性剂的Brij 76,以pEGFP-LUC为模型质粒来制备基于Precirol ATO 5的阳离子固体脂质纳米粒(cSLN)。cSLN的物理化学性质受表面活性剂的类型和用量影响。大量cSLN的热分析显示吸热峰与单一纯组分的吸热峰显著不同,这表明脂质基质与表面活性剂完全缠结,并解释了cSLN在与质粒DNA相互作用能力方面的不同行为。最后,通过溶血试验证明了cSLN的生物相容性。这些结果可能有助于深入了解表面活性剂的选择,以便获得用于基因治疗的无毒且高效的递送系统。

相似文献

1
Surfactant effect on the physicochemical characteristics of cationic solid lipid nanoparticles.表面活性剂对阳离子固体脂质纳米粒理化特性的影响。
Int J Pharm. 2017 Jan 10;516(1-2):334-341. doi: 10.1016/j.ijpharm.2016.11.052. Epub 2016 Nov 23.
2
Design, Physical Characterizations, and Biocompatibility of Cationic Solid Lipid Nanoparticles in HCT-116 and 16-HBE Cells: A Preliminary Study.阳离子固体脂质纳米粒的设计、物理特性鉴定及其在 HCT-116 和 16-HBE 细胞中的生物相容性:初步研究。
Molecules. 2023 Feb 10;28(4):1711. doi: 10.3390/molecules28041711.
3
Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration.固体脂质纳米粒作为基因治疗的潜在工具:静脉给药后的体内蛋白表达。
Int J Pharm. 2010 Jan 29;385(1-2):157-62. doi: 10.1016/j.ijpharm.2009.10.020. Epub 2009 Oct 14.
4
A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: development, characterization and DNA binding efficiency of TCERG1 expression plasmid.一种用于基因递送的新型阳离子固体脂质纳米粒优化制剂:TCERG1表达质粒的研发、表征及DNA结合效率
Int J Pharm. 2014 Oct 1;473(1-2):270-9. doi: 10.1016/j.ijpharm.2014.06.022. Epub 2014 Jul 3.
5
Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies.阳离子固体脂质纳米粒(cSLN):结构、稳定性与 DNA 结合能力相关性研究。
Int J Pharm. 2011 Nov 28;420(2):341-9. doi: 10.1016/j.ijpharm.2011.08.042. Epub 2011 Sep 2.
6
Spectroscopic study on interaction between three cationic surfactants with different alkyl chain lengths and DNA.不同烷基链长度的三种阳离子表面活性剂与DNA相互作用的光谱研究
Spectrochim Acta A Mol Biomol Spectrosc. 2015;151:237-46. doi: 10.1016/j.saa.2015.06.114. Epub 2015 Jun 29.
7
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.阳离子固体脂质纳米粒的 pDNA 缩合能力和体外基因传递特性。
Int J Pharm. 2010 Apr 15;389(1-2):254-61. doi: 10.1016/j.ijpharm.2010.01.030. Epub 2010 Jan 25.
8
Enhancement of DNA compaction by negatively charged nanoparticles: effect of nanoparticle size and surfactant chain length.带负电荷的纳米颗粒增强 DNA 压缩:纳米颗粒尺寸和表面活性剂链长的影响。
J Colloid Interface Sci. 2012 Feb 15;368(1):372-7. doi: 10.1016/j.jcis.2011.10.033. Epub 2011 Oct 20.
9
Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.聚乙二醇共轭金纳米颗粒的物理化学性质及生物相容性评估:一种用于小干扰RNA递送的制剂策略。
Colloids Surf B Biointerfaces. 2015 Nov 1;135:604-612. doi: 10.1016/j.colsurfb.2015.08.032. Epub 2015 Aug 24.
10
Solid lipid nanoparticles: formulation factors affecting cell transfection capacity.固体脂质纳米粒:影响细胞转染能力的制剂因素
Int J Pharm. 2007 Jul 18;339(1-2):261-8. doi: 10.1016/j.ijpharm.2007.03.015. Epub 2007 Mar 12.

引用本文的文献

1
Modular Synthesis of Dendritic Oligo-Glycerol Cationic Surfactants for Enhanced Antibacterial Efficacy.用于增强抗菌功效的树枝状低聚甘油阳离子表面活性剂的模块化合成
Angew Chem Int Ed Engl. 2025 May 26;64(22):e202425069. doi: 10.1002/anie.202425069. Epub 2025 Apr 14.
2
Lipid-based nanoparticles: innovations in ocular drug delivery.基于脂质的纳米颗粒:眼部药物递送的创新
Front Mol Biosci. 2024 Sep 17;11:1421959. doi: 10.3389/fmolb.2024.1421959. eCollection 2024.
3
Breaking Barriers: Nanomedicine-Based Drug Delivery for Cataract Treatment.
突破障碍:基于纳米医学的白内障治疗药物输送。
Int J Nanomedicine. 2024 May 6;19:4021-4040. doi: 10.2147/IJN.S463679. eCollection 2024.
4
Development and Characterization of Cationic Nanostructured Lipid Carriers as Drug Delivery Systems for miRNA-27a.阳离子纳米结构脂质载体作为miRNA - 27a药物递送系统的开发与表征
Pharmaceuticals (Basel). 2023 Jul 14;16(7):1007. doi: 10.3390/ph16071007.
5
Microfluidic encapsulation of enzymes and steroids within solid lipid nanoparticles.微流控技术将酶和甾体包封于固体脂质纳米粒中。
Drug Deliv Transl Res. 2024 Jan;14(1):266-279. doi: 10.1007/s13346-023-01398-5. Epub 2023 Jul 28.
6
Design, Physical Characterizations, and Biocompatibility of Cationic Solid Lipid Nanoparticles in HCT-116 and 16-HBE Cells: A Preliminary Study.阳离子固体脂质纳米粒的设计、物理特性鉴定及其在 HCT-116 和 16-HBE 细胞中的生物相容性:初步研究。
Molecules. 2023 Feb 10;28(4):1711. doi: 10.3390/molecules28041711.
7
Solid Lipid Nanoparticles Loaded with Nisin (SLN-Nisin) are More Effective Than Free Nisin as Antimicrobial, Antibiofilm, and Anticancer Agents.载有乳链菌肽的固体脂质纳米粒(SLN-Nisin)作为抗菌、抗生物膜和抗癌剂比游离乳链菌肽更有效。
J Biomed Nanotechnol. 2022 Apr 1;18(4):1227-1235. doi: 10.1166/jbn.2022.3314.
8
Surfactant Effect on the Physicochemical Characteristics of Solid Lipid Nanoparticles Based on Pillar[5]arenes.基于[5]轮芳烃的固体脂质纳米粒的表面活性剂对其理化特性的影响。
Int J Mol Sci. 2022 Jan 11;23(2):779. doi: 10.3390/ijms23020779.
9
Microfluidics Technology for the Design and Formulation of Nanomedicines.用于纳米药物设计与制剂的微流控技术
Nanomaterials (Basel). 2021 Dec 18;11(12):3440. doi: 10.3390/nano11123440.
10
Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo Studies.用于局部眼部治疗的克拉霉素固体脂质纳米粒:优化、评价及体内研究
Pharmaceutics. 2021 Apr 9;13(4):523. doi: 10.3390/pharmaceutics13040523.